Sex Differences in Circadian Clock Genes and Myocardial Infarction Susceptibility.
Ivana SkrlecJasminka TalapkoMartina JuzbašićRobert SteinerPublished in: Journal of cardiovascular development and disease (2021)
The growing body of evidence shows a significant difference in the circadian rhythm of cardiovascular disease based on biological sex. The incidence of cardiovascular disease varies between women and men. Additionally, biological sex is vital for the timely application of therapy-chronotherapy, which benefits both sexes. This study aimed to examine the potential difference of single nucleotide polymorphisms (SNPs) of the circadian rhythm genes ARNTL, CLOCK, CRY2 and PER2 in women and men with myocardial infarction. A cross-sectional study was conducted, including 200 patients with myocardial infarction. Altogether, ten single nucleotide polymorphisms in the ARNTL, CLOCK, CRY2 and PER2 genes were analyzed. The Chi-square test yielded statistically significant differences in CLOCK gene rs11932595 polymorphism in a recessive genotype model between women and men with a p-value of 0.03 and an odds ratio 2.66, and a corresponding 95% confidence interval of 1.07 to 6.66. Other analyzed polymorphisms of the circadian rhythm genes ARNTL, CRY2, and PER2 did not significantly differ between the sexes. According to the study's current results, the CLOCK gene's genetic variability might affect myocardial infarction concerning biological sex.
Keyphrases
- genome wide
- genome wide identification
- cardiovascular disease
- heart failure
- polycystic ovary syndrome
- left ventricular
- dna methylation
- copy number
- genome wide analysis
- heart rate
- type diabetes
- bioinformatics analysis
- transcription factor
- risk factors
- gene expression
- pregnant women
- insulin resistance
- stem cells
- metabolic syndrome
- cervical cancer screening
- mesenchymal stem cells
- skeletal muscle
- risk assessment
- autism spectrum disorder
- adipose tissue